<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03496311</url>
  </required_header>
  <id_info>
    <org_study_id>CSF acid-base in pregnancy</org_study_id>
    <nct_id>NCT03496311</nct_id>
  </id_info>
  <brief_title>Cerebrospinal Acid-base in Pregnant and Non-pregnant Fertile Women</brief_title>
  <official_title>Effects of Pregnancy on the Physico-chemical Characteristics of Cerebrospinal Acid-base Equilibrium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The third trimester of pregnancy is typically characterized by the development of a marked
      respiratory alkalosis. The possible role of pregnancy-induced variations of cerebrospinal
      fluid (CSF) acid-base characteristics on the development of hypocapnic alkalosis is still
      unknown.

      Aim of this study is to characterize, according to Stewart's approach, the acid-base
      equilibrium of CSF and arterial plasma of pregnant women and compare the results with data
      obtained from fertile, non-pregnant women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The reduction in plasma PCO2 correlates with gestational age and was shown to be associated
      to plasma progesterone concentrations. We hypothesize that pregnancy-related haemodilution,
      inducing a reduction in CSF Strong Ion Difference (SID), might have a role in the development
      of pregnancy-related hypocapnic alkalosis.

      Samples of CSF and arterial plasma of pregnant women with gestational age &gt; 35 weeks
      undergoing spinal anesthesia for elective caesarean section will be analyzed for blood gases,
      pH, electrolytes, osmolality, albumin and haemoglobin concentration. In addition plasma
      copeptin levels will be analyzed. The same measurements will be performed in fertile,
      non-pregnant women undergoing spinal anesthesia for elective surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 13, 2018</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Strong Ion Difference</measure>
    <time_frame>1 day</time_frame>
    <description>Strong Ion Difference (expressed in milliequivalents per Liter [mEq/L]) of cerebrospinal fluid and arterial plasma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Partial pressure of carbon dioxide (PCO2)</measure>
    <time_frame>1 day</time_frame>
    <description>PCO2 (expressed in millimeters of Mercury [mmHg]) of cerebrospinal fluid and arterial plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sum of albumin (expressed in mmol/L) and Phosphates (expressed in mmol/L)</measure>
    <time_frame>1 day</time_frame>
    <description>The total amount of weak non carbonic acids, i.e. the sum of albumin and phosphates (both expressed in mmol/L) of cerebrospinal fluid and arterial plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference between cerebrospinal fluid and arterial plasma Strong Ion Difference (Delta SID)</measure>
    <time_frame>1 day</time_frame>
    <description>The difference between plasma and cerebrospinal fluid SID (expressed in mEq/L) will be calculated as marker of electrolyte inbalance between these two extracellular fluid compartments. Delta SID = SIDcsf - SIDplasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference between cerebrospinal fluid and arterial plasma partial pressure of CO2 (Delta PCO2)</measure>
    <time_frame>1 day</time_frame>
    <description>The difference between cerebrospinal fluid and arterial plasma PCO2 (expressed in mmHg) will be calculated as a marker of acid-base equilibrium between these two extracellular fluid compartments. Delta PCO2 = SIDplasma - SIDcsf</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progesterone levels</measure>
    <time_frame>1 day</time_frame>
    <description>Plasma and CSF Progesterone levels (expressed in ng/mL) will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Copeptin levels</measure>
    <time_frame>1 day</time_frame>
    <description>Plasma copeptin levels (expressed in pmol/L) will be measured as a marker of antidiuretic hormone activity</description>
  </secondary_outcome>
  <other_outcome>
    <measure>SID PCO2 correlation</measure>
    <time_frame>1 day</time_frame>
    <description>Correlation between CSF SID and PCO2</description>
  </other_outcome>
  <other_outcome>
    <measure>Osmolality PCO2 correlation</measure>
    <time_frame>1 day</time_frame>
    <description>Correlation between CSF osmolality and PCO2</description>
  </other_outcome>
  <other_outcome>
    <measure>Plasma progesterone PCO2 correlation</measure>
    <time_frame>1 day</time_frame>
    <description>Correlation between plasma progesterone concentration and plasma PCO2</description>
  </other_outcome>
  <other_outcome>
    <measure>CSF progesterone PCO2 correlation</measure>
    <time_frame>1 day</time_frame>
    <description>Correlation between CSF progesterone concentration and CSF PCO2</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Acid-Base Imbalance</condition>
  <condition>Respiratory Alkalosis</condition>
  <condition>Cerebrospinal Fluid</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Pregnant Women</arm_group_label>
    <description>Pregnant women with gestational age &gt; 35 weeks undergoing spinal anesthesia for elective cesarean section.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Fertile, non-pregnant women undergoing spinal anesthesia for elective surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Acid - Base characterization</intervention_name>
    <description>Samples of cerebrospinal fluid and arterial blood will be collected anaerobically to measure acid-base variables, electrolytes, albumin, progesterone and copeptin levels</description>
    <arm_group_label>Pregnant Women</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      samples of plasma and cerebrospinal fluid
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing spinal anesthesia either for elective cesarean section of for elective
        surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnancy with gestational age &gt; 35 weeks

          -  Scheduled elective cesarean section under spinal anesthesia

        Exclusion Criteria:

          -  known respiratory or neurologic disease

          -  multiple pregnancies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Langer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Milan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Pesenti, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Milan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edoardo Calderini, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico di Milano</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giorgio Giudici, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Milan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mariateresa Ambrosini, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico di Milano</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Langer, MD</last_name>
    <phone>+390250320463</phone>
    <email>thomas.langer@unimi.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Langer, MD</last_name>
      <email>thomas.langer@unimi.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2018</study_first_submitted>
  <study_first_submitted_qc>April 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alkalosis</mesh_term>
    <mesh_term>Acid-Base Imbalance</mesh_term>
    <mesh_term>Alkalosis, Respiratory</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

